No Data
No Data
DarioHealth Announces Two New Studies Presented At ADA Scientific Sessions; Research Confirms Sustainable Behavior Change Over 12 Months With Dario Digital Platform; 31% Of Dario Members With Type 2 Diabetes Achieve Diabetes Remission; Analysis...
DarioHealth Announces Two New Studies Presented At ADA Scientific Sessions; Research Confirms Sustainable Behavior Change Over 12 Months With Dario Digital Platform; 31% Of Dario Members With Type 2 D
Express News | Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1
Slammed 42% DarioHealth Corp. (NASDAQ:DRIO) Screens Well Here But There Might Be A Catch
DarioHealth Corp. (NASDAQ:DRIO) shares have had a horrible month, losing 42% after a relatively good period beforehand. For any long-term shareholders, the last month ends a year to forget by locki
TD Cowen Maintains DarioHealth(DRIO.US) With Buy Rating, Maintains Target Price $5
TD Cowen analyst Charles Rhyee maintains $DarioHealth(DRIO.US)$ with a buy rating, and maintains the target price at $5.According to TipRanks data, the analyst has a success rate of 47.4% and a total
Express News | Dariohealth: Establish dedicated executive positions for each core function to report directly to the CEO.
Express News | Dariohealth appoints Steven Nelson as its Chief Commercial Officer.